OTC Markets OTCPK - Delayed Quote USD

(SRAMF)

3.6000

0.0000

(0.00%)

At close: April 28 at 4:00:00 PM EDT

Sisram Medical Announces 2024 Annual Results

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approaches including Energy-Based Devices (EBD), Injectables, alongside other complementary offerings, announced its audited consolidated annual results for the year ended December 31, 2024 (the "Reporting Period").

PR Newswire last month

1696.HK
Sisram Medical to Report FY 2024 Financial Results on March 19 and Hold a Conference Call on March 20

Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, emphasizing on energy-based devices and injectables, alongside other complementary offerings, today announced that it expects to release its financial results for FY 2024, ended December 31, on Wednesday, March 19, 2024.

PR Newswire last month

1696.HK
Sirsram Medical announces NMPA approval for DAXXIFY®

Sisram Medical (1696.HK), a global leading innovator and provider of holistic medical aesthetic solutions announced today that the National Medical Products Administration has accepted the Biologics License Application ("BLA") for the Company's botulinum toxin, DAXXIFY® (Chinese trademark: 达希斐®), intended for the temporary improvement in the appearance of moderate to severe glabellar lines caused by movements associated with corrugator and/or procures muscle activity in adult patients. As the fi

PR Newswire 7 months ago

1696.HK
Sisram Medical Announces First-Half 2024 Financial Results

Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approach, including energy-based devices, injectables, aesthetics and digital dentistry, personal care, and more, today announced its unaudited consolidated interim results for the six months ended June 30, 2024 (the "Reporting Period").

PR Newswire 8 months ago

1696.HK
Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22

Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, including Energy Based Devices, Injectables, Aesthetic and Digital Dentistry, Personal Care, and more, today announced that it expects to release its financial results for H1 2024, ended June 30, on Wednesday, August 21, 2024.

PR Newswire 8 months ago

1696.HK

Performance Overview

Return	SRAMF	HANG SENG INDEX (^HSI)
YTD	--	+9.71%
1-Year	+4.59%	+24.01%
3-Year	+14.88%	+4.36%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(SRAMF)

Sisram Medical Announces 2024 Annual Results

Sisram Medical to Report FY 2024 Financial Results on March 19 and Hold a Conference Call on March 20

Sirsram Medical announces NMPA approval for DAXXIFY®

Sisram Medical Announces First-Half 2024 Financial Results

Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22

Performance Overview